Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis

NCT01377363 is registered in ClinicalTrials.gov with Spanish Breast Cancer Research Group as lead sponsor.

NCT NCT01377363
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01377363 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Degree of Conversion of HER2 Receptor Between Primary Breast Cancer and Metastasis
Lead sponsor
Spanish Breast Cancer Research Group
Phase
Observational
Overall status
Completed
Start date
December 11, 2009
Completion date
November 30, 2012
Enrollment
236 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer